Vivos Therapeutics (VVOS) Total Debt Growth (1y) (2020 - 2021)

Vivos Therapeutics (VVOS) Total Debt Growth (1y) (2020 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 157.11%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -12.26%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 5.50%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -2.48%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 0.12%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 15.70%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 19.06%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -5.48%
10 Vivos Therapeutics 8.16 Mn 5.93 Mn 3.06 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 -1.94%
Dec 31, 2020 -65.22%